Acebrophylline Sustained Release, Desloratadine & Montelukast Sodium Tablets – Philbro DM Tablets

Acebrophylline Sustained Release, Desloratadine & Montelukast Sodium Tablets – Breathe easier with triple-action therapy for full-day respiratory relief.

Philbro DM Tablets: The composition of Acebrophylline 200mg (SR) + Desloratadine 5mg + Montelukast Sodium 10 mg offers a synergistic approach for managing chronic respiratory and allergic conditions. Acebrophylline provides sustained bronchodilation and anti-inflammatory effects by modulating inflammatory mediators and relaxing airway muscles. Desloratadine is a potent antihistamine that reduces allergy symptoms such as nasal congestion and sneezing. Montelukast is a leukotriene receptor antagonist that prevents airway inflammation and bronchoconstriction.

Recommended bY Specialists:
Pulmonologists -It is preferred to treat the disease associated with Asthma, COPD, and allergic
General Physicians –It is prefer to treat the disease associated for routine management of allergic bronchitis, mild Asthma.
Immunologists –It is preferred to treat the disease associated with chronic allergies involving the respiratory tract.

Key Benefits of Acebrophylline Sustained Release, Desloratadine & Montelukast Sodium Tablets – Philbro DM Tablets:
Triple-Action Therapy: Combines bronchodilation, anti-inflammatory, and antihistaminic effects for comprehensive respiratory care.
Bilayered Technology: Ensures sustained release of Acebrophylline and immediate action of Desloratadine and Montelukast for optimal efficacy.
Allergen Control: Effectively manages allergic triggers and reduces airway inflammation for enhanced respiratory function.

INDICATIONS:
Allergic Rhinitis with Asthma
Chronic Obstructive Pulmonary Disease (COPD) with Allergies
Bronchial Asthma associated with Allergic Triggers